These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25910605)

  • 1. [Therapeutic inertia in the management of type 2 diabetic patients in Primary Health Care].
    Vernet Vernet M; Sender Palacios MJ; Bautista Galí L; Larrosa Sàez P; Vargas Sánchez J
    Semergen; 2016 Apr; 42(3):152-7. PubMed ID: 25910605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of therapeutic inertia and the degree of the medication adherence on the control goals for patients with diabetes].
    López-Simarro F; Moral I; Aguado-Jodar A; Cols-Sagarra C; Mancera-Romero J; Alonso-Fernández M; Miravet-Jiménez S; Brotons C
    Semergen; 2018; 44(8):579-585. PubMed ID: 29174068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inertia and treatment compliance in patients with type 2 diabetes in primary care].
    López-Simarro F; Brotons C; Moral I; Cols-Sagarra C; Selva A; Aguado-Jodar A; Miravet-Jiménez S
    Med Clin (Barc); 2012 Apr; 138(9):377-84. PubMed ID: 22036458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
    Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
    Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic inertia amongst general practitioners with interest in diabetes.
    Seidu S; Than T; Kar D; Lamba A; Brown P; Zafar A; Hussain R; Amjad A; Capehorn M; Martin E; Fernando K; McMoran J; Millar-Jones D; Kahn S; Campbell N; Brice R; Mohan R; Mistry M; Kanumilli N; St John J; Quigley R; Kenny C; Khunti K
    Prim Care Diabetes; 2018 Feb; 12(1):87-91. PubMed ID: 28993141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2008; 65(6):277-82. PubMed ID: 18853658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [INERTIA study: Clinical inertia in non-insulinized patients on oral hypoglycemic treatment. A study in Spanish primary and specialty care settings].
    González-Clemente JM; Font B; Lahoz R; Llauradó G; Gambús G;
    Med Clin (Barc); 2014 Jun; 142(11):478-84. PubMed ID: 23622897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Inertia in Type 2 Diabetes Patients in Primary Health Care Clinics in Central Bosnia.
    Marjanović M; Vrdoljak D; Bralić Lang V; Polašek O; Đido V; Kašćel Fišić M; Mađar Šimić I; Dodig D; Radoš Perić M
    Med Sci Monit; 2018 Nov; 24():8141-8149. PubMed ID: 30421728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care delivery in type 2 diabetes. A survey in an Italian primary care practice.
    Modesti A; Bartaloni R; Bellagamba F; Caglieri R; Cenori K; Ciampalini G; Costagli A; Galloni V; Del Papa C; Modesti L; Dell'Omo G; Pedrinelli R
    Prim Care Diabetes; 2015 Feb; 9(1):9-14. PubMed ID: 24908631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of type 2 diabetes mellitus in Spain today: identification of the main obstacles in daily clinical practice].
    Torres IV; Donlo IC
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():3-6. PubMed ID: 24444517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service.
    Ahmed AA; Alsharief E; Alsharief A
    Diabetes Metab Syndr; 2013; 7(3):133-7. PubMed ID: 23953177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes care and complications in primary care in the Tshwane district of South Africa.
    Webb EM; Rheeder P; Van Zyl DG
    Prim Care Diabetes; 2015 Apr; 9(2):147-54. PubMed ID: 24933340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus.
    Salinero-Fort MA; Carrillo-de Santa Pau E; Arrieta-Blanco FJ; Abanades-Herranz JC; Martín-Madrazo C; Rodés-Soldevila B; de Burgos-Lunar C
    BMC Public Health; 2011 Apr; 11():267. PubMed ID: 21524316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 19. Organizational determinants of high-quality routine diabetes care.
    van Doorn-Klomberg AL; Braspenning JC; Wolters RJ; Bouma M; de Grauw WJ; Wensing M
    Scand J Prim Health Care; 2014 Sep; 32(3):124-31. PubMed ID: 25264939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usage of fasting glucose and glycated hemoglobin for the identification of unknown type 2 diabetes in high risk patients with morbid obesity.
    Valderhaug TG; Sharma A; Kravdal G; Rønningen R; Nermoen I
    Scand J Clin Lab Invest; 2017 Nov; 77(7):505-512. PubMed ID: 28715238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.